EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+24.65%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$262M
AUM Growth
+$262M
(+19%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
75.81%
Holding
46
New
12
Increased
5
Reduced
5
Closed
13
Top Buys
| 1 |
Ardelyx
ARDX
|
$17M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$15M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$10.6M |
| 4 |
KA
Kineta, Inc. Common Stock
KA
|
$9.39M |
| 5 |
DERM
Dermira, Inc.
DERM
|
$8.45M |
Top Sells
| 1 |
Travere Therapeutics
TVTX
|
$21.8M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$12.6M |
| 3 |
Cytokinetics
CYTK
|
$11.9M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$9.51M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$7.73M |
Sector Composition
| 1 | Healthcare | 85.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ironwood Pharmaceuticals
IRWD
$214M
| $44.6M | 13.69% | 2,810,315 +379,864 | +16% | +$6.03M |
|
2
Galapagos
GLPG
$2.07B
| $32.4M | 9.93% | 500,576 +61,191 | +14% | +$3.96M |
|
3
Assembly Biosciences
ASMB
$190M
| $21.2M | 6.51% | 2,943,164 | – | – |
|
|
DERM
4
DELISTED
Dermira, Inc.
DERM
| $17.7M | 5.42% | 522,000 +250,000 | +92% | +$8.45M |
|
|
5
Ardelyx
ARDX
$1.53B
| $17M | 5.2% | +1,310,023 | New | +$17M |
|
6
Kura Oncology
KURA
$686M
| $16.3M | 5.01% | 2,611,906 +146,620 | +6% | +$916K |
|
|
FPRX
7
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $15M | 4.62% | +286,612 | New | +$15M |
|
8
FibroGen
FGEN
$47.8M
| $14.2M | 4.36% | 686,184 -102,561 | -13% | -$2.12M |
|
|
9
Agios Pharmaceuticals
AGIO
$2.19B
| $10.6M | 3.24% | +200,000 | New | +$10.6M |
|
|
KA
10
DELISTED
Kineta, Inc. Common Stock
KA
| $9.39M | 2.88% | +602,315 | New | +$9.39M |
|
|
AKAO
11
DELISTED
Achaogen, Inc.
AKAO
| $8.05M | 2.47% | 1,679,707 +107,999 | +7% | +$517K |
|
|
12
Cytokinetics
CYTK
$4.23B
| $7.77M | 2.38% | 846,654 -1,293,043 | -60% | -$11.9M |
|
|
KIN
13
DELISTED
Kindred Biosciences, Inc.
KIN
| $7.15M | 2.19% | 1,432,765 | – | – |
|
14
Syndax Pharmaceuticals
SNDX
$1.41B
| $5.42M | 1.66% | 357,365 | – | – |
|
|
ONC
15
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $5.04M | 1.55% | 163,470 -11,910 | -7% | -$367K |
|
16
Ascendis Pharma
ASND
$11.8B
| $4.41M | 1.35% | +219,200 | New | +$4.41M |
|
|
ONCE
17
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $4.12M | 1.26% | +68,600 | New | +$4.12M |
|
18
Adverum Biotechnologies
ADVM
$64.6M
| $3.89M | 1.19% | +946,263 | New | +$3.89M |
|
|
NBRV
19
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $3.87M | 1.19% | 548,912 -13,829 | -2% | -$97.5K |
|
20
Intellia Therapeutics
NTLA
$1.22B
| $3.42M | 1.05% | 200,858 -109,837 | -35% | -$1.87M |
|
|
CMRX
21
DELISTED
Chimerix, Inc.
CMRX
| $3.31M | 1.02% | +598,062 | New | +$3.31M |
|
|
OMED
22
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $3.04M | 0.93% | +265,784 | New | +$3.04M |
|
23
Fate Therapeutics
FATE
$120M
| $1.84M | 0.57% | +590,527 | New | +$1.84M |
|
|
SYRS
24
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $882K | 0.27% | +63,596 | New | +$882K |
|
|
AKTX
25
Akari Therapeutics
AKTX
$24.8M
| – | – | -63,468 | Closed | -$856K |
|